Long-term Oxygen Treatment Trial
Public ClinicalTrials.gov record NCT00692198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease With Moderate Desaturation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Chronic obstructive pulmonary disease (COPD) is a serious respiratory disease in which the airways in the lungs are partially blocked, resulting in symptoms of chest tightness, coughing, and difficulty breathing. Currently, there are many available treatments for managing COPD symptoms and improving quality of life, including medications, lifestyle changes, oxygen therapy, and pulmonary rehabilitation. For people with severe COPD that is characterized by very low blood oxygen levels at rest, long term oxygen therapy can help to prolong life and promote feelings of well-being. However, the effectiveness of supplemental oxygen therapy for people with COPD that is characterized by only moderately low blood oxygen levels at rest or normal blood oxygen at rest and desaturation on exercise is not known. This study will evaluate the effectiveness of supplemental oxygen therapy in treating people with COPD who have moderately low blood oxygen levels at rest or who have normal blood oxygen levels at rest, but have low or very low blood oxygen levels during exercise.
Study identification
- NCT ID
- NCT00692198
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 738 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Jul 31, 2015
- Completion
- Jul 31, 2015
- Last update posted
- May 9, 2017
2009 – 2015
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham VA Medical Center | Birmingham | Alabama | 35233 | — |
| University of Alabama | Birmingham | Alabama | 35294 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Loma Linda VA Medical Center | Loma Linda | California | 92357 | — |
| Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Los Angeles | California | 90502 | — |
| UCSD Medical Center | San Diego | California | 92103 | — |
| Denver Health and Hospital Authority | Denver | Colorado | 80204 | — |
| National Jewish Medical and Research Center | Denver | Colorado | 80206 | — |
| North Florida/South Georgia VA | Gainseville | Florida | 32608 | — |
| Central Florida Pulmonary Group | Orlando | Florida | 32803 | — |
| Weston Florida Cleveland Clinic | Weston | Florida | 33331 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Suburban Lung Associates | Elk Grove Village | Illinois | 60007 | — |
| Louisiana State University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| Boston VA Medical Center | West Roxbury | Massachusetts | 02132 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Pulmonary Consultants Inc./Christian Hospital | St Louis | Missouri | 63136 | — |
| Buffalo VAMC | Buffalo | New York | 14215 | — |
| Crouse Medical Practice | Syracuse | New York | 13210 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Cincinnati VA Medical Center | Cincinnati | Ohio | 45220 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Kaiser Foundation Hospitals | Portland | Oregon | 97232 | — |
| Geisinger Institute | Danville | Pennsylvania | 17822 | — |
| Institute for Respiratory and Sleep Medicine | Langhorne | Pennsylvania | 19047 | — |
| Temple University | Philadelphia | Pennsylvania | 19140 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Respiratory Specialists | Wyomissing | Pennsylvania | 19610 | — |
| University of Texas at San Antonio | San Antonio | Texas | 78249 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Harborview Medical Center | Seattle | Washington | 98101 | — |
| University of Washington | Seattle | Washington | 98101 | — |
| Puget Sound VA Medical Center | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00692198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00692198 live on ClinicalTrials.gov.